Epigenetic inhibition of adaptive bypass responses to lapatinib by targeting BET Bromodomains

Por Stuhlmiller, Timothy J., Miller, Samantha M., Johnson, Gary L.
Publicado no Mol Cell Oncol (2015)

Weight loss reduces basal-like breast cancer through kinome reprogramming

Por Qin, Yuanyuan, Sundaram, Sneha, Essaid, Luma, Chen, Xin, Miller, Samantha M., Yan, Feng, Darr, David B., Galanko, Joseph A., Montgomery, Stephanie A., Major, Michael B., Johnson, Gary L., Troester, Melissa A., Makowski, Liza
Publicado no Cancer Cell Int (2016)

Role of HGF in epithelial–stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ

Por Casbas-Hernandez, Patricia, D’Arcy, Monica, Roman-Perez, Erick, Brauer, Heather Ann, McNaughton, Kirk, Miller, Samantha M, Chhetri, Raghav K, Oldenburg, Amy L, Fleming, Jodie M, Amos, Keith D, Makowski, Liza, Troester, Melissa A
Publicado em 2013

Inhibition of Lapatinib-induced Kinome Reprogramming in ERBB2-positive Breast Cancer by Targeting BET Family Bromodomains

Por Stuhlmiller, Timothy J., Miller, Samantha M., Zawistowski, Jon S., Nakamura, Kazuhiro, Beltran, Adriana S., Duncan, James S., Angus, Steven P., Collins, Kyla A. L., Granger, Deborah A., Reuther, Rachel A., Graves, Lee M., Gomez, Shawn M., Kuan, Pei-Fen, Parker, Joel S., Chen, Xin, Sciaky, Noah, Carey, Lisa A., Earp, H. Shelton, Jin, Jian, Johnson, Gary L.
Publicado no Cell Rep (2015)